barr 954 Pill - beige capsule/oblong, 14mm
Pill with imprint barr 954 is Beige, Capsule/Oblong and has been identified as Dextroamphetamine Sulfate Extended Release 5 mg. It is supplied by Teva Pharmaceuticals USA.
Dextroamphetamine is used in the treatment of ADHD; Narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dextroamphetamine 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for barr 954
Dextroamphetamine Sulfate Extended Release
- Imprint
- barr 954
- Strength
- 5 mg
- Color
- Beige
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00555-0954 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
dibutyl sebacate,
methylcellulose (15 mPa.s),
povidone k30,
propylene glycol,
sucrose,
corn starch,
magnesium silicate,
D&C Red No. 33,
FD&C Blue No. 1,
FD&C Yellow No. 6,
titanium dioxide,
D&C Yellow No. 10,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Red No. 40,
shellac,
ferrosoferric oxide
Note: Inactive ingredients may vary.
More about dextroamphetamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (294)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
- Dextroamphetamine drug information
- Dextroamphetamine Tablets
- Dextroamphetamine Sustained-Release Capsules
- Dextroamphetamine Oral Solution
Other brands
Dexedrine, Zenzedi, Dextrostat, ProCentra, ... +2 more
Professional resources
- Dextroamphetamine monograph
- Dextroamphetamine (FDA)
- Dextroamphetamine ER (FDA)
- Dextroamphetamine Extended-Release Capsules (FDA)
- Dextroamphetamine Oral Solution (FDA)
Other brands
Dexedrine, Zenzedi, Dextrostat, ProCentra, Xelstrym
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.